The Human Cancer PrimaCell™ 8: Glioma Cells is for rapid (7-10 days) isolation and growth of human glioma cells from human glioma tumor tissues. This system features an optimal condition of tissue dissociation system, Cancer OptiTDS™ that yields 6-8 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium.

Human Cancer PrimaCell™ 8 System (Cat No. 2-96031):
Human Cancer PrimaCell™ 8: Glioma Cells Protocols
Human Cancer Tissue Preparation Buffer 8: Glioma Cells Cells
Human Cancer OptiTDS™ 8: Tissue Dissociation System
Human Cancer PrimaCell™ 8: Glioma Cells Growth Medium
Human Cancer PrimaCell™ 8: Glioma Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Leske H, Haase R, Restle F, Schichor C, Albrecht V, Vizoso Pinto MG, Tonn JC, Baiker A, Thon N. Varicella zoster virus infection of malignant glioma cell cultures: a new candidate for oncolytic virotherapy? Anticancer Res. 2012 Apr;32(4):1137-44.
[2] Tao J, Qiu B, Zhang D, Wang Y. Expression levels of Fas/Fas-L mRNA in human brain glioma stem cells. Mol Med Report. 2012 May;5(5):1202-6. doi: 10.3892/mmr.2012.791. Epub 2012 Feb 15.
[3] Odemis V, Lipfert J, Kraft R, Hajek P, Abraham G, Hattermann K, Mentlein R, Engele J. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells. Glia. 2012 Mar;60(3):372-81. doi: 10.1002/glia.22271. Epub 2011 Nov 14.